Pacira Pharmaceuticals(PCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCRX Pacira Pharmaceuticals

盘后交易 10-10 19:48:23 EDT

22.35

-0.71

-3.08%

盘后22.00

-0.35-1.57%

17:28 EDT

最高23.06	最低22.30	成交量43.27万
今开23.06	昨收23.06	日振幅3.32%
总市值10.04亿	流通市值8.90亿	总股本4,493万
成交额973.12万	换手率1.09%	流通股本3,983万
市净率1.33	ROE-15.57%	每股收益-2.81
52周最高27.64	52周最低15.50	市盈率-7.96
股息0.00	股息收益率0.00	ROA2.69%

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCRX","market":"US","secType":"STK","nameCN":"Pacira Pharmaceuticals","latestPrice":22.35,"timestamp":1760126400000,"preClose":23.06,"halted":0,"volume":432687,"hourTrading":{"tag":"盘后","latestPrice":22,"preClose":22.35,"latestTime":"17:28 EDT","volume":14345,"amount":320631.83715,"timestamp":1760131738188},"delay":0,"floatShares":39826611,"shares":44932721,"eps":-2.806275,"marketStatus":"盘后交易","change":-0.71,"latestTime":"10-10 19:48:19 EDT","open":23.06,"high":23.06,"low":22.295,"amount":9731178.22557,"amplitude":0.033174,"askPrice":25.14,"askSize":100,"bidPrice":20.01,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-2.806275,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1760140800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1296709200000,"exchange":"NASDAQ","adjPreClose":23.06,"postHourTrading":{"tag":"盘后","latestPrice":22,"preClose":22.35,"latestTime":"17:28 EDT","volume":14345,"amount":320631.83715,"timestamp":1760131738188},"volumeRatio":0.848431,"impliedVol":0.7867,"impliedVolPercentile":0.888},"requestUrl":"/m/hq/s/PCRX","defaultTab":"news","newsList":[{"id":"2558681748","title":"Pacira Biosciences, Inc.2025财年第二财季实现净利润-4.85百万美元，同比减少125.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558681748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558681748?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841693,"startTime":"0","endTime":"0","summary":"8月11日，Pacira Biosciences, Inc.公布财报，公告显示公司2025财年第二财季净利润为-4.85百万美元，同比减少125.67%；其中营业收入为1.81亿美元，同比增加1.69%，每股基本收益为-0.11美元。从资产负债表来看，Pacira Biosciences, Inc.总负债7.79亿美元，其中短期债务2.12亿美元，资产负债比为1.98，流动比率为2.39。机构评级：截至2025年8月11日，当前有5家机构对Pacira Biosciences, Inc.目标价做出预测，其中目标均价为30.80美元，其中最低目标价为24.00美元，最高目标价为44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000343a4805784&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000343a4805784&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX"],"gpt_icon":0},{"id":"2558579663","title":"Pacira Biosciences, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558579663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558579663?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:26","pubTimestamp":1754674015,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时26分，Pacira Biosciences, Inc.股票出现波动，股价快速上涨5.07%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.02%。其相关个股中，Canopy Growth Corporation、Ani Pharmaceuticals, Inc.、Amphastar Pharmaceuticals, Inc.涨幅较大，Incannex Healthcare Inc.、Canopy Growth Corporation、Ani Pharmaceuticals, Inc.较为活跃，换手率分别为164.18%、19.26%、6.33%，振幅较大的相关个股有Canopy Growth Corporation、Alpha Teknova, Inc.、Incannex Healthcare Inc.，振幅分别为31.43%、27.42%、21.49%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809012655a47dab4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809012655a47dab4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2557567841","title":"Pacira Biosciences, Inc.盘中异动 早盘急速拉升5.00%报23.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557567841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557567841?lang=zh_cn&edition=full","pubTime":"2025-08-07 23:23","pubTimestamp":1754580204,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日23时23分，Pacira Biosciences, Inc.股票出现波动，股价急速上涨5.00%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为5.83%。其相关个股中，Emergent Biosolutions Inc.、Elanco Animal Health Incorporated、Ironwood医药涨幅较大，Incannex Healthcare Inc.、Emergent Biosolutions Inc.、Akebia Therapeutics, Inc.较为活跃，换手率分别为42.65%、3.06%、2.59%，振幅较大的相关个股有Ironwood医药、Avadel Pharmaceuticals Plc、Medicus Pharma Ltd C/Wts 15/11/2029，振幅分别为33.54%、23.42%、19.86%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807232325a6d922e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807232325a6d922e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2557590308","title":"Pacira Biosciences, Inc.盘中异动 早盘大幅拉升5.04%报23.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557590308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557590308?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:48","pubTimestamp":1754488112,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时48分，Pacira Biosciences, Inc.股票出现波动，股价急速上涨5.04%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为1.13%。其相关个股中，Siga Technologies Inc.、Citius Oncology, Inc.、博美集团涨幅较大，Evoke Pharma, Inc.、Incannex Healthcare Inc.、Lantheus Holdings, Inc.较为活跃，换手率分别为18.84%、17.56%、3.82%，振幅较大的相关个股有坎伯兰药业、Cardiol Therapeutics Inc.、Flora Growth Corp.，振幅分别为17.15%、10.37%、10.03%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621483394d38265&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621483394d38265&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2557339327","title":"Pacira Biosciences, Inc.盘中异动 临近收盘快速拉升5.12%报23.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557339327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557339327?lang=zh_cn&edition=full","pubTime":"2025-08-05 03:52","pubTimestamp":1754337172,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时52分，Pacira Biosciences, Inc.股票出现异动，股价急速上涨5.12%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.69%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805035252a6d2e821&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805035252a6d2e821&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2556302845","title":"Pacira Biosciences, Inc.盘中异动 临近收盘股价大涨5.00%报22.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556302845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556302845?lang=zh_cn&edition=full","pubTime":"2025-08-02 03:56","pubTimestamp":1754078175,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日03时56分，Pacira Biosciences, Inc.股票出现波动，股价快速拉升5.00%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为1.68%。其相关个股中，Evoke Pharma, Inc.、苏轩堂、美国联合医疗涨幅较大，Akanda Corp.、Incannex Healthcare Inc.、Evoke Pharma, Inc.较为活跃，换手率分别为361.32%、194.83%、22.18%，振幅较大的相关个股有Akanda Corp.、Evoke Pharma, Inc.、Incannex Healthcare Inc.，振幅分别为60.53%、44.90%、19.76%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802035615a4704340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802035615a4704340&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2536758219","title":"Pacira Biosciences, Inc.2025财年第一财季实现净利润4.81百万美元，同比减少46.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536758219","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536758219?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497636,"startTime":"0","endTime":"0","summary":"5月18日，Pacira Biosciences, Inc.公布财报，公告显示公司2025财年第一财季净利润为4.81百万美元，同比减少46.44%；其中营业收入为1.69亿美元，同比增加1.20%，每股基本收益为0.10美元。从资产负债表来看，Pacira Biosciences, Inc.总负债7.88亿美元，其中短期债务2.11亿美元，资产负债比为2.02，流动比率为2.42。机构评级：截至2025年5月18日，当前有6家机构对Pacira Biosciences, Inc.目标价做出预测，其中目标均价为36.17美元，其中最低目标价为24.00美元，最高目标价为65.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000253a6e2d88b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000253a6e2d88b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX"],"gpt_icon":0},{"id":"2535005462","title":"Pacira Biosciences, Inc.盘中异动 下午盘急速上涨5.00%报24.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535005462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535005462?lang=zh_cn&edition=full","pubTime":"2025-05-15 01:15","pubTimestamp":1747242944,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日01时15分，Pacira Biosciences, Inc.股票出现异动，股价大幅拉升5.00%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为2.61%。其相关个股中，Incannex Healthcare Inc.、Inmed Pharmaceuticals Inc.、Medicus Pharma Ltd.涨幅较大，Incannex Healthcare Inc.、Petros Pharmaceuticals, Inc.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为4456.07%、1250.06%、194.62%，振幅较大的相关个股有Incannex Healthcare Inc.、Inmed Pharmaceuticals Inc.、Petros Pharmaceuticals, Inc.，振幅分别为727.78%、52.29%、38.33%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515011544aa2c8ee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515011544aa2c8ee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007"],"gpt_icon":0},{"id":"2535620086","title":"Pacira Biosciences, Inc.盘中异动 下午盘急速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535620086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535620086?lang=zh_cn&edition=full","pubTime":"2025-05-14 03:04","pubTimestamp":1747163041,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日03时04分，Pacira Biosciences, Inc.股票出现波动，股价急速跳水5.06%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为1.32%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051403040297589a41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051403040297589a41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX","BK4007","BFRI"],"gpt_icon":0},{"id":"1116857573","title":"异动解读 | 业绩不及预期，Pacira Pharmaceuticals盘中大跌7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116857573","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116857573?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:34","pubTimestamp":1746797698,"startTime":"0","endTime":"0","summary":"周五交易时段，生物制药公司Pacira Pharmaceuticals股价出现大幅下跌，盘中跌幅达7.67%，引发市场广泛关注。这一显著跌幅主要源于公司最新发布的季度财报未能达到市场预期。根据公司公布的财务报告，尽管Pacira Pharmaceuticals第一季度调整后每股收益为62美分，略高于分析师平均预期的60美分，但公司营收表现令人失望。值得注意的是，近期分析师对Pacira Pharmaceuticals的盈利预期已有所下调。投资者将密切关注公司未来的业绩表现和市场反应。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PCRX"],"gpt_icon":0},{"id":"1159888826","title":"异动解读 | 业绩不及预期，Pacira Pharmaceuticals盘中大跌7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159888826","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159888826?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:34","pubTimestamp":1746797695,"startTime":"0","endTime":"0","summary":"周五盘中，Pacira Pharmaceuticals股价大幅下跌7.67%，延续了夜盘的跌势。这一显著跌幅主要源于公司最新发布的季度财报未能满足市场预期。值得注意的是，近期分析师对Pacira Pharmaceuticals的盈利预期有所下调。这些负面调整进一步加剧了投资者的担忧，推动了股价的持续下跌。尽管公司今年以来的股价表现较好，但这次业绩报告似乎未能满足市场的期望，导致股价出现大幅回调。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PCRX"],"gpt_icon":0},{"id":"2534253480","title":"Pacira Biosciences, Inc.盘中异动 早盘股价大跌7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534253480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534253480?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:33","pubTimestamp":1746797608,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时33分，Pacira Biosciences, Inc.股票出现波动，股价急速跳水7.19%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.53%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213328a4783d56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213328a4783d56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"1129000686","title":"异动解读 | 业绩欠佳致Pacira Pharmaceuticals夜盘大跌7.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1129000686","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129000686?lang=zh_cn&edition=full","pubTime":"2025-05-09 14:41","pubTimestamp":1746772860,"startTime":"0","endTime":"0","summary":"周五夜盘，Pacira Pharmaceuticals股价大幅下跌7.99%，引发市场关注。这一跌幅可能与公司最新发布的季度财报有关。根据公司公布的财报，截至3月31日的季度调整后每股收益为62美分，略高于分析师平均预期的60美分。值得注意的是，近期分析师对Pacira Pharmaceuticals的盈利预期有所下调。这些负面调整可能加剧了投资者的担忧，进一步推动了股价下跌。尽管公司今年以来的股价表现较好，但这次业绩报告似乎未能满足市场的期望，导致股价在夜盘交易中出现大幅回调。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 业绩欠佳致Pacira Pharmaceuticals夜盘大跌7.99%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PCRX"],"gpt_icon":0},{"id":"2531267350","title":"Pacira Biosciences, Inc.盘中异动 大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531267350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531267350?lang=zh_cn&edition=full","pubTime":"2025-04-29 03:55","pubTimestamp":1745870157,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日03时55分，Pacira Biosciences, Inc.股票出现异动，股价急速上涨5.17%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.27%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504290355579748ece7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504290355579748ece7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX","UPC"],"gpt_icon":0},{"id":"2529802188","title":"Pacira Biosciences, Inc.盘中异动 大幅上涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529802188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529802188?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:31","pubTimestamp":1745242293,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时31分，Pacira Biosciences, Inc.股票出现波动，股价快速拉升5.42%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.10%。其相关个股中，Sunshine Biopharma Inc.、Cardiol Therapeutics Inc.、Medicus Pharma Ltd.涨幅较大，Sunshine Biopharma Inc.、Redhill Biopharma Ltd、苏轩堂较为活跃，换手率分别为147.12%、3.01%、1.58%，振幅较大的相关个股有Sunshine Biopharma Inc.、大自然药业、Alpha Teknova, Inc.，振幅分别为8.00%、6.74%、6.25%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213133aa2c73b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213133aa2c73b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2518447094","title":"Pacira Biosciences, Inc.2024财年实现净利润-99.56百万美元，同比减少337.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518447094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518447094?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449618,"startTime":"0","endTime":"0","summary":"3月9日，Pacira Biosciences, Inc.公布财报，公告显示公司2024财年净利润为-99.56百万美元，同比减少337.27%；其中营业收入为7.01亿美元，同比增加3.85%，每股基本收益为-2.15美元。从资产负债表来看，Pacira Biosciences, Inc.总负债7.75亿美元，其中短期债务2.11亿美元，资产负债比为2.01，流动比率为2.41。机构评级：截至2025年3月9日，当前有7家机构对Pacira Biosciences, Inc.目标价做出预测，其中目标均价为30.86美元，其中最低目标价为21.00美元，最高目标价为48.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000024abef96df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000024abef96df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCRX"],"gpt_icon":0},{"id":"2516663179","title":"Pacira Biosciences, Inc.盘中异动 股价大跌5.11%报22.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663179?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:44","pubTimestamp":1741034657,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时44分，Pacira Biosciences, Inc.股票出现异动，股价急速下挫5.11%。截至发稿，该股报22.82美元/股，成交量68.1483万股，换手率1.47%，振幅5.30%。Pacira Biosciences, Inc.股票所在的制药行业中，整体涨幅为0.77%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044417989a6239&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044417989a6239&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2516583648","title":"巴克莱：维持Pacira BioSciences(PCRX.US)评级，由增持调整至增持评级, 目标价由17.00美元调整至24.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516583648","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516583648?lang=zh_cn&edition=full","pubTime":"2025-03-01 07:12","pubTimestamp":1740784345,"startTime":"0","endTime":"0","summary":"巴克莱：维持Pacira BioSciences(PCRX.US)评级，由增持调整至增持评级, 目标价由17.00美元调整至24.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01071248470461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PCRX"],"gpt_icon":0},{"id":"2516777379","title":"Pacira Biosciences, Inc.盘中异动 早盘大幅跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516777379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516777379?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:11","pubTimestamp":1740759087,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时11分，Pacira Biosciences, Inc.股票出现异动，股价急速下跌5.02%。Pacira Biosciences, Inc.股票所在的制药行业中，整体跌幅为0.17%。其相关个股中，Organogenesis Holdings Inc.、百利高、Sunshine Biopharma Inc C/Wts 涨幅较大，Organogenesis Holdings Inc.、苏轩堂、Petros Pharmaceuticals, Inc.较为活跃，换手率分别为31.48%、11.69%、8.11%，振幅较大的相关个股有Organogenesis Holdings Inc.、Sunshine Biopharma Inc C/Wts 、苏轩堂，振幅分别为57.65%、44.90%、18.00%。Pacira Biosciences, Inc.公司简介：Pacira BioSciences Inc 是一家非阿片类疼痛管理和再生健康解决方案的提供商，致力于推进和改善医疗从业者及其患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301001127a2581ab5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301001127a2581ab5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCRX"],"gpt_icon":0},{"id":"2514353594","title":"Pacira BioSciences(PCRX.US)：2024年Q4财报实现营收1.873亿美元，前值为1.812亿美元，预期值为1.854亿美元；每股收益为0.91美元，前值为0.89美元，预期值为0.83美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514353594","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514353594?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:21","pubTimestamp":1740691300,"startTime":"0","endTime":"0","summary":"Pacira BioSciences(PCRX.US)：2024年Q4财报实现营收1.873亿美元，前值为1.812亿美元，预期值为1.854亿美元；每股收益为0.91美元，前值为0.89美元，预期值为0.83美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28052148442333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PCRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pacira.com","stockEarnings":[{"period":"1week","weight":-0.0618},{"period":"1month","weight":-0.1232},{"period":"3month","weight":0.007},{"period":"6month","weight":-0.0611},{"period":"1year","weight":0.4801},{"period":"ytd","weight":0.224}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.032},{"period":"3month","weight":0.0762},{"period":"6month","weight":0.257},{"period":"1year","weight":0.1629},{"period":"ytd","weight":0.1452}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pacira BioSciences, Inc.成立于2006年12月，自2007年3月以来一直在开展与EXPAREL相关的业务。该公司是一家专注于开发、商业化和制造医药产品的专业制药公司，基于公司专有的DepoFoam给药技术，主要用于医院和门诊手术中心。该公司经营一个可报告的分部。2011年10月28日，美国食品药品监督管理局（FDA）批准了公司的新药申请，即NDA，用于公司的主要候选产品EXPAREL，一种布比卡因的脂质体注射液，一种适用于浸润到手术部位以产生术后镇痛长达72小时的酰胺型局部麻醉剂。该公司认为，EXPAREL解决了对长效非阿片类术后镇痛剂的重大未满足的医疗需求，从而简化了术后疼痛管理并减少了阿片类药物的消耗，从而改善了患者的治疗效果并提高了医院经济效益。公司发展了一支完全致力于将EXPAREL商业化的内部销售队伍，公司于2012年4月将其商业化推出。此外，继试点计划后，自2013年10月1日起，公司任命CrossLink BioScience，LLC或CrossLink作为独家第三方分销商，为期五年，在美国推广和销售用于骨科和脊柱手术的EXPAREL，但某些地理区域和账户除外，可能会根据双方协议进行变更和调整。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.06786},{"month":2,"riseRate":0.642857,"avgChangeRate":0.021525},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.005065},{"month":4,"riseRate":0.6,"avgChangeRate":0.040098},{"month":5,"riseRate":0.533333,"avgChangeRate":0.021597},{"month":6,"riseRate":0.4,"avgChangeRate":0.013306},{"month":7,"riseRate":0.4,"avgChangeRate":-0.031855},{"month":8,"riseRate":0.533333,"avgChangeRate":0.016779},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.011519},{"month":10,"riseRate":0.266667,"avgChangeRate":-0.023384},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063401},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038038}],"exchange":"NASDAQ","name":"Pacira Pharmaceuticals","nameEN":"Pacira Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pacira Pharmaceuticals(PCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pacira Pharmaceuticals(PCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pacira Pharmaceuticals,PCRX,Pacira Pharmaceuticals股票,Pacira Pharmaceuticals股票老虎,Pacira Pharmaceuticals股票老虎国际,Pacira Pharmaceuticals行情,Pacira Pharmaceuticals股票行情,Pacira Pharmaceuticals股价,Pacira Pharmaceuticals股市,Pacira Pharmaceuticals股票价格,Pacira Pharmaceuticals股票交易,Pacira Pharmaceuticals股票购买,Pacira Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pacira Pharmaceuticals(PCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pacira Pharmaceuticals(PCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}